BSH Guideline: Diagnosis and therapy of genetic haemochromatosis (2017 update)

BSG-endorsed British Society for Haematology (BSH) guidelines on haemochromatosis

Genetic haemochromatosis (GH) is one of the most frequent genetic disorders found in Northern Europeans. GH is a condition caused by continued absorption of iron from the upper small intestine, despite normal, and then increased, total body iron. This leads to accumulation of iron in the tissues as the body has no means of getting rid of excess iron.

In advanced disease, iron accumulation causes widespread tissue damage, including diabetes mellitus and cirrhosis. The disorder is inherited in autosomal recessive fashion. The gene involved lies close to the HLA-A region on chromosome 6. This updated guideline follows on from the previously published guideline commissioned by the British Committee for Standards in Haematology in February 2000 (Dooley & Worwood, 2000). This review and updated guidance coincides with the development of a separate guideline on the investigation and management of a raised serum ferritin, also commissioned by the BSH guidelines committee.

Read More

BSG logo
Position Statements
Liver
BSG position statement on the American Association for the Study of Liver Disease practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis
clinical-resource/BSG-AASLD-position-statement-cirrhosis
The British Society of Gastroenterology (BSG) recognises that the current UK guideline on the management of variceal bleeding in cirrhotic patients (2015) requires updating.

BSG logo
Clinical Resources
Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)
clinical-resource/MHRA-DSI-on-the-Allurion-Gastric-Balloon
In rare instances, the Allurion Gastric Balloon has not transited through the stomach or bowel as intended, leading to complications.